Would I be wrong in thinking that by being remunerated to the tune of millions every year and handed millions more in bonus (free!) CUV, this guy might possibly be being slightly disingenuous and taking full advantage of regulators time squandering stonewalling of scenesse?
Probably believing that they have to relax the draconian restrictions they unjustly placed onto scenesse one day, so why bother putting in the required effort and working up a sweat to see things happen years sooner, when sitting back pretty socialising with no name influencers and “intriguing” obscure maestro’s and travelling the world while waiting these people out, is a much more satisfying lifestyle and way way WAY more lucrative “in the end”.
Imagine where this company’s SP would be if safe scenesse were available off label to those vulnerable (10s of millions) to skin cancer if scenesse were available in an injector pen just like Ozempic (semaglutide)?
Not possible?
CUV Price at posting:
$15.99 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)